ArticleGut2016

Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation.

Toshihiro Matsukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.